- Home
- PSTV vs NBY Comparison
PSTV vs NBY Comparison
Compare PSTV & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSTV
- NBY
- Stock Information
- Founded
- PSTV 1996
- NBY 2000
- Country
- PSTV United States
- NBY United States
- Employees
- PSTV N/A
- NBY N/A
- Industry
- PSTV Medical/Dental Instruments
- NBY
- Sector
- PSTV Health Care
- NBY
- Exchange
- PSTV Nasdaq
- NBY Nasdaq
- Market Cap
- PSTV 17.0M
- NBY 15.7M
- IPO Year
- PSTV N/A
- NBY 2007
- Fundamental
- Price
- PSTV $0.89
- NBY $1.21
- Analyst Decision
- PSTV Strong Buy
- NBY Strong Buy
- Analyst Count
- PSTV 4
- NBY 1
- Target Price
- PSTV $8.00
- NBY $0.85
- AVG Volume (30 Days)
- PSTV 42.6M
- NBY 1.2M
- Earning Date
- PSTV 11-13-2025
- NBY 11-06-2025
- Dividend Yield
- PSTV N/A
- NBY N/A
- EPS Growth
- PSTV N/A
- NBY N/A
- EPS
- PSTV N/A
- NBY 0.41
- Revenue
- PSTV $5,317,000.00
- NBY $9,781,000.00
- Revenue This Year
- PSTV $28.09
- NBY $23.91
- Revenue Next Year
- PSTV N/A
- NBY $32.05
- P/E Ratio
- PSTV N/A
- NBY $3.52
- Revenue Growth
- PSTV N/A
- NBY 113.47
- 52 Week Low
- PSTV $0.16
- NBY $0.46
- 52 Week High
- PSTV $2.31
- NBY $4.44
- Technical
- Relative Strength Index (RSI)
- PSTV 71.94
- NBY 40.93
- Support Level
- PSTV $0.59
- NBY $1.22
- Resistance Level
- PSTV $0.87
- NBY $1.64
- Average True Range (ATR)
- PSTV 0.08
- NBY 0.24
- MACD
- PSTV 0.04
- NBY -0.16
- Stochastic Oscillator
- PSTV 91.32
- NBY 0.38
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.